Article
The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome.
Journal of human genetics - 1 Sept 2017
Sugiura-Ogasawara Mayumi, Omae Yosuke, Kawashima Minae, Toyo-Oka Licht, Khor Seik-Soon, Sawai Hiromi, Horita Tetsuya, Atsumi Tatsuya, Murashima Atsuko, Fujita Daisuke, Fujita Tomio, Morimoto Shinji, Morishita Eriko, Katsuragi Shinji, Kitaori Tamao, Katano Kinue, Ozaki Yasuhiko, Tokunaga Katsushi
Abstract excerpt
Antiphospholipid syndrome (APS) is the most important treatable cause of recurrent pregnancy loss. The live birth rate is limited to only 70-80% in patients with APS undergoing established anticoagulant therapy. Lupus anticoagulant (LA), but not anticardiolipin antibody (aCL), was found to predict adverse pregnancy outcome. Recent genome-wide association studies (GWAS) of APS focusing on aCL have shown that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
